Home  »  Finance   »  Right Now May Be the Best Buy-In Window for Contra...

Right Now May Be the Best Buy-In Window for ContraFect Corporation (CFRX)

ContraFect Corporation (CFRX) is priced at $0.15 after the most recent trading session. At the very opening of the session, the stock price was $0.13 and reached a high price of $0.1495, prior to closing the session it reached the value of $0.14. The stock touched a low price of $0.13.Recently in News on November 22, 2022, CFRX: Exebacase to be Evaluated as Treatment for Prosthetic Joint Infections…. By David Bautz, PhD. You can read further details here

ContraFect Corporation had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.5400 on 06/10/22, with the lowest value was $0.1275 for the same time period, recorded on 11/10/22.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


ContraFect Corporation (CFRX) full year performance was -95.85%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ContraFect Corporation shares are logging -96.80% during the 52-week period from high price, and 13.80% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.13 and $4.54.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3695387 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the ContraFect Corporation (CFRX) recorded performance in the market was -94.87%, having the revenues showcasing -49.25% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 5.72M, as it employees total of 38 workers.

Analysts verdict on ContraFect Corporation (CFRX)

During the last month, 0 analysts gave the ContraFect Corporation a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.4324, with a change in the price was noted -2.95. In a similar fashion, ContraFect Corporation posted a movement of -95.08% for the period of last 100 days, recording 1,730,199 in trading volumes.

ContraFect Corporation (CFRX): Technical Analysis

Raw Stochastic average of ContraFect Corporation in the period of last 50 days is set at 22.22%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 39.37%. In the last 20 days, the company’s Stochastic %K was 25.88% and its Stochastic %D was recorded 28.94%.

Let’s take a glance in the erstwhile performances of ContraFect Corporation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -94.87%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -96.24%, alongside a downfall of -95.85% for the period of the last 12 months. The shares increased approximately by -3.98% in the 7-day charts and went up by -15.62% in the period of the last 30 days. Common stock shares were lifted by -49.25% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts